Danaher net earnings increase 9% to $597 million in Q3 2013

Danaher Corporation (NYSE: DHR) today announced results for the third quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations and all references to increases in financial metrics reflect year-over-year changes, unless otherwise noted.

For the quarter ended September 27, 2013, net earnings were $597.0 million, or $0.84 per share on a diluted basis, a 9.0% increase. Revenues increased 5.5% to $4.7 billion with core revenues increasing 3.0%.

The Company anticipates that GAAP diluted net earnings per share for the quarter ending December 31, 2013 will be in the range of $0.91 to $0.96.  The Company reaffirmed its full year 2013 adjusted diluted net earnings per share guidance of $3.37 to $3.42.

H. Lawrence Culp, Jr., President and Chief Executive Officer, stated, "Our team has continued to execute well using the Danaher Business System to deliver solid core revenue growth, operating margin expansion and cash flow performance in the quarter. Our new product development and go-to-market investments are driving relative outperformance in many of our businesses.  We believe our focus on accelerating our growth spending and our productivity and efficiency initiatives, combined with our optimism on the acquisition front, position us well for the balance of 2013 and beyond."


Danaher Corporation

Posted in: Business / Finance

Tags: ,



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
UIC to determine whether exercise can shorten recovery time for stem cell transplant patients